Skip to main content
Clinical Trials/NCT03007069
NCT03007069UnknownNot Applicable

Implant Insertion in Defective Anterior Maxillary Ridge Augmented Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft

Cairo University0 sites20 target enrollmentStarted: January 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
20
Primary Endpoint
Patient Satisfaction regarding esthetic results , outcome will be measure using questionnaire.

Study Overview

Brief Summary

Using growth factors obtained from patient's venous blood mixed with particulate autogenous bone the study compares bone gain by implant with gold standards.

Detailed Description

To study the effectiveness of MPM in ridge augmentation with implant insertion compared with autogenous bone graft.

-PICO-

Population (P): Patients with defective maxillary alveolar ridge requiring implant insertion.

Intervention (I): Ridge augmentation with MPM.

Comparator (C): Autogenous bone graft.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Medically free patients.
  • •Evaluated bone height on CBCT to be (0-4 mm buccal bone dehiscence) and width (not less than 4.5 mm)
  • •Patients with Anterior maxillary defective partially edentulous ridge.
  • •Age between 18 and 40 years.
  • •Both sexes.
  • •Patients physically able to tolerate surgical and restorative procedures.
  • •Patients with an opposing tooth to the pre-implant site.
  • •Good oral hygiene.
  • •Highly motivated patients.

Exclusion Criteria

  • •Patients allergic to local anesthetic agent.
  • •Pregnant or lactating females.
  • •Presence of any pathosis in the pre-implant site.
  • •Presence of any mucosal disease.
  • •Presence of parafunctional habits.
  • •History of oral radiotherapy.
  • •History of prolonged steroids use.
  • •Psychological disorders.

Arms & Interventions

Autogenous bone graft (Gold Standard).

Experimental

Patients with defective maxillary alveolar ridges requiring implant insertion will have Autogenous bone graft (Gold standard) and collagen membrane to be used for bone augmentation around exposed threads of inserted dental implants.

Intervention: Autogenous bone graft (gold standard). (Other)

MPM Augmentation.

Active Comparator

Mineralized plasmatic matrix (MPM) to be used without collagen membrane to augment the defect in the maxillary bone and cover the exposed threads of the dental implants.

Intervention: Mineralized plasmatic matrix (MPM). (Other)

Outcomes

Primary Outcomes

Patient Satisfaction regarding esthetic results , outcome will be measure using questionnaire.

Time Frame: 5 months

Secondary Outcomes

  • Stability of dental implants , this will be measured using Ostell device in ISQ units.(5 months.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mahmoud Usama Mahmoud El Masry

Dentist at menistry of health

Cairo University

Similar Trials